 |
December 15, 2008
Dr. Sergio Oehninger Receives HealthCare Hero Award
Inside Business, a business journal in Hampton Roads, Virginia, has recognized Dr. Sergio Oehninger, Director of the Jones Institute, as one of its 2008 “HealthCare Heroes” in Southeast Virginia. Dr. Oehninger received the award based on his achievements in reproductive medicine and his subsequent contribution to the improvement and advancement of medicine in Virginia. The award epitomizes the spirit embodied in the word “hero” in the delivery of health care to the community. The purpose of the program is to recognize excellence, promote innovation, encourage emulation of successful programs, educate the general public and contribute to the enhancement of the value and quality of health care by recognizing those who are most deserving.
Dr. Oehninger was profiled in a special supplement of Inside Business and was presented an award at a banquet on February 9, 2009.
Read More...
July 25, 2008
NORFOLK, VA — Just ahead of the
30th birthday of the world’s first “test tube baby,” the
first person born in the U.S. through in-vitro
fertilization (IVF) visited the place that made her
birth possible.
Elizabeth Comeau, along with her husband, David, stopped
in to see Howard Jones, M.D., and take a look around the
institute that pioneered IVF science in this country.
Her arrival also triggered an impromptu reunion as
several members of the team that worked at the institute
in its early days came by to check in on their first
success story.
After catching up with Jones — the two speak at least
annually — Comeau, now a journalist for the Boston
Globe, got a look at how far infertility science has
come since her mother went through the IVF procedure.
Thousands of babies later, the once hours-long,
uncomfortable process now takes a matter of minutes.
“It was very primitive compared to how it is now,” said Comeau.
Images and story courtesy of Eastern Virginia Medical
School
The Shirley D. Kheel Lectureship featured Dr. Pasquale
Patrizio, Yale Fertility Center,
February 28, 2008
Professor Pasquale Patrizio, MD,
MBE, HCLD, Director of the Division of Reproductive
Medicine at the Yale Fertility Center, discussed
“Strategies for Fertility Preservation” as the annual
Jones Institute Foundation Shirley Dungan Kheel
lectureship program on February 28, 2008. Dr. Patrizio
spoke about the current strategies for fertility
preservation in females and males with cancer and/or
those who may be at risk of losing gonadal tissue due to
other conditions.
Strategies for Fertility Preservation by Pasquale
Patrizio, M.D.
Jones-Andrews Scholars in
Reproductive Medicine
February, 2008

The Jones Institute hosted two scientists in
residence during the month of February. Dr. Jose
Horcajadas and Dr. Vanesa Rawe each spent several days
at the Institute instructing and collaborating with
physicians and scientists as part of the Jones-Andrews
Scholars in Reproductive Medicine.
Dr. Hocajadas is an instructor at the Instituto
Valenciano de Infertilidad, Valencia, Spain.
Dr. Rawe is an instructor at the Center of Gynecological
and Reproductive Studies, Buenos Aires, Argentina.
John D. Gearhart, Ph.D. “Embryonic Stem Cell Research: A
Status Report”
Dr.
Gearhart, a Professor of Gynecology and Obstetrics,
Physiology and Comparative Medicine and Population
Dynamics at Johns Hopkins University School of Medicine,
was the guest speaker at the Jones Institute’s Clinical
Embryology & Andrology Master’s Program on May 21, 2007.
As the Director of Stem Cell Biology at Johns Hopkins,
Dr. Gearhart is a pioneer in human pluripotent stem cell
research. His leadership in the Stem Cell Biology effort
focuses on understanding the natural life cycle of human
embryonic germ cells, which were first isolated in
Gearhart’s lab.
Click
here for the entire article.
Spring/April 2007 Jones Journal
The Jones Institute has opened a new outpatient
surgical center which is designed to provide patients
with a private and comfortable setting for all of their
infertility treatment – from the initial consultation to
the post-operative care. The second floor of the Jones
Institute, which formerly housed administrative offices,
has been completely renovated so that many of the
comprehensive medical services that were previously
performed at neighboring Norfolk Sentara General
Hospital, may now be handled in the Institute.
Click
here for the entire article.

Ari
Babaknia, M.D., founder and CEO of DrSoy Nutrition, LLC,
spoke to physicians and residents on So(y)lution to
Menopausal Health
Dr.
Ari Babaknia, Clinical Associate Professor, Dept. of OB/GYN,
University of California, Irvine spoke to the OB/GYN
practicing physicians and residents on September 7, 2006
about the benefits of using soy to enhance menopausal
health. He discussed the evidence in medical literature
that supports the use of this non-hormonal nutrition
therapy as an alternative to traditional hormone
replacement therapy. Click
here for the entire article.
The Jones Institute Recognizes Two Outstanding
Students
At the Eastern Virginia Medical School graduation on May
20, 2006, the Clinical Embryology and Andrology Master’s
Degree program of the Jones Institute presented two of
their graduates with awards for outstanding achievement.
These awards are significant for two reasons. New to the
list of EVMS graduation awards, these distinctions
recognize two students who have completed a complex
distance learning program and they honor two late
pioneers in the field of reproductive medicine. Dr.
Georgeanna Seegar Jones and Dr. Gary D. Hodgen were
members of the faculty and research team at the Jones
Institute prior to their deaths in 2005.
Click here for the entire article.
Jones Institute study seeks to preserve fertility in
young cancer patients
Each year, 50,000 women in the United States under the
age of 40 are diagnosed with cancer. One in 1,000 girls
will be diagnosed with and survive childhood cancer.
For these young cancer patients, the very treatment that
is often the best hope to save their lives can also rob
them of their dreams to one day have children.
Chemotherapy and radiation cause premature ovarian
failure in a significant proportion of these women. Bone
marrow or stem cell transplants -- combined with other
adjuvant treatments that are used in many forms of
pediatric cancer -- cause a loss of ovarian reserve in
95 percent of patients.
Click here for the entire article.
Jones Institute Foundation Wins Birth-control Patent
Fight With EVMS
By BILL SIZEMORE, The Virginian-Pilot, © January 26, 2006
Dean’s Faculty Achievement Awards
Clinical Service Award
Dr. Sergio Oehninger was one of five
faculty members who were honored at the
eastern Virginia Medical Schools Annual
Dean’s Faculty Achievement Awards on June
1, 2005.
Just a few hours before flying off to
Europe to serve as a guest speaker at two
scientific organizations, Sergio
Oehninger, M.D., Ph.D., paused for a few
minutes between patients to reflect on
his prolific career in reproductive
medicine and his love of his profession.
“Even though it sound s soap-operaish,
the fact that you get to help people get
pregnant, conceive and establish a family
is wonderful,” he said.
It is not unusual to catch Oehninger
between tasks, and when one reflects on
his resume, it is easy to see why.
Oehninger, professor of obstetrics and
gynecology and urology, is also director
of the Division of Reproductive Medicine
at EVMS. He has three graduate degrees –
an M.D., a Ph.D., and a M.S. – and
juggles work as a clinician, researcher
and mentor. For his extraordinary
contributions to Eastern Virginia Medical
School, Oehninger received the Dean’s
Faculty Achievement Award in Clinical
Service.
“Everything we have achieved depends on
the group of people we have working with
us – nurses, andrologists, embryologists
and our colleagues – that’s why I’m
here,” Oehninger said upon accepting his
award.
One colleague, in acknowledging
Oehninger’s outstanding resume, said:
“What impresses me the most is the volume
of his scholarly production. While taking
care of patients in the operating room,
the hospital and the clinic all day long,
Dr. Oehninger has managed to publish more
than 200 peer-reviewed papers and over 35
book chapters, reviews and other
publications.” The colleague goes on to
note that Oehninger participates in
numerous EVMS committees, reviews
manuscripts for 12 medical journals,
directs and teaches national and
international courses in andrology and
infertility and writes Grant proposals
for his funded research.
Oehninger said he became interested in
obstetric and gynecology because it
combines surgery with endocrinology and
medicine. In the early 1980s, the
then-new fields of IVF and advanced
reproductive technology piqued his
interest and led to his decision to
sub-specialize in reproductive
endocrinology and infertility.
Infertility also has its frustrations, he
conceded.
“It’s true that the coin has two sides,”
he said. “Not all treatments are
efficient in everyone and we are
disappointed many times, but the
successes far outweigh the failures and
it is wonderful that we can help.”
Oehninger’s work, in conjunction with
colleagues from the Department of
Urology, has led to expanded treatment
options for a special population of
infertile men. He has also spearheaded
research to transplant frozen ovarian
tissue into chemotherapy/cancer-surviving
patients, give them hope that they may
one day have children of their own
|
 |
 |